Octodrine

Octodrine

Clinical data
Other names	DMHA; Ottodrina; Vaporpac; Amidrine; 2-Aminoisoheptane; 2-Amino-6-methylheptane; 1,5-Dimethylhexylamine; 6-Methyl-2-heptylamine; 6-Methyl-2-heptanamine
Routes of administration	Oral, inhaled
ATC code	none
Legal status
Legal status	Not currently marketed anywhere, hydrochloride salt is sold as a designer drug online.
Identifiers
IUPAC name 6-methylheptan-2-amine
CAS Number	543-82-8 N
PubChem CID	10982
ChemSpider	10517
UNII	3GQ9E911BI
CompTox Dashboard (EPA)	DTXSID8046535
ECHA InfoCard	100.008.047
Chemical and physical data
Formula	C8H19N
Molar mass	129.247 g·mol−1
3D model (JSmol)	Interactive image
SMILES CC(C)CCCC(C)N
InChI InChI=1S/C8H19N/c1-7(2)5-4-6-8(3)9/h7-8H,4-6,9H2,1-3H3 Key:QNIVIMYXGGFTAK-UHFFFAOYSA-N
(verify)

Octodrine (also known as Vaporpac or DMHA) is a stimulant drug whose pharmacology was studied in a dozen animal studies from the 1940s through the 1970s. These studies found that octodrine can increase blood pressure and cardiac output in animals. The drug was previously approved for use by the FDA as an inhalant (i.e., Vaporpac and Tickle Tackle Inhaler) and in Germany as an oral agent as part of a multicomponent medication (i.e., Ambredin and Ordinal), but is no longer available.

DMHA has also been found as an adulterant in sports supplements and is sold online as a designer drug.

Related designer drugs

• Methylhexanamine
• 1,3-Dimethylbutylamine (DMBA)